Previous close | 0.1800 |
Open | 0.1800 |
Bid | 0.0000 |
Ask | 2.2000 |
Strike | 185.00 |
Expiry date | 2024-01-19 |
Day's range | 0.1800 - 0.1800 |
Contract range | N/A |
Volume | |
Open interest | 745 |
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's Monoject syringes. The health regulator said Alaris pumps are validated for use with Monoject syringes.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety Communication on evaluation of certain plastic syringes: